1. Impact of different Sofosbuvir-based direct acting antiviral (DAA) regimen in elderly cirrhotic patients: A real world experience from CLEO Group. (10th February 2016) Authors: Pellicelli, A.M.; Pace Palitti, V.; Vignally, P.; Moretti, A.; Tarquini, P.; Scifo, G.; Messina, V.; Ascione, A.; Izzi, A.; D'Ambrosio, C.; Villani, R.; Fondacaro, L.; Fontanella, L.; Guarascio, P.; Alessio, L.; Miglioresi, L.; D'amico, E.; Ettorre, G.M.; Marignani, M.; Begini, P. Journal: Digestive and liver disease Issue: Volume 48(2016)Supplement 1 Page Start: e42 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗